WO2019209374A1 - Sequenced droplet ejection to deliver fluids - Google Patents

Sequenced droplet ejection to deliver fluids Download PDF

Info

Publication number
WO2019209374A1
WO2019209374A1 PCT/US2018/062365 US2018062365W WO2019209374A1 WO 2019209374 A1 WO2019209374 A1 WO 2019209374A1 US 2018062365 W US2018062365 W US 2018062365W WO 2019209374 A1 WO2019209374 A1 WO 2019209374A1
Authority
WO
WIPO (PCT)
Prior art keywords
chamber
fluid
channel
droplet ejector
droplet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2018/062365
Other languages
French (fr)
Inventor
John LAHMANN
Pavel Kornilovich
Silam J. Choy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hewlett Packard Development Co LP
Original Assignee
Hewlett Packard Development Co LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2018/029169 external-priority patent/WO2019209273A1/en
Priority claimed from PCT/US2018/042411 external-priority patent/WO2020018074A1/en
Priority claimed from PCT/US2018/042416 external-priority patent/WO2020018075A1/en
Priority claimed from PCT/US2018/042408 external-priority patent/WO2020018073A1/en
Application filed by Hewlett Packard Development Co LP filed Critical Hewlett Packard Development Co LP
Priority to US17/045,873 priority Critical patent/US11931738B2/en
Publication of WO2019209374A1 publication Critical patent/WO2019209374A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/50273Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502715Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02Adapting objects or devices to another
    • B01L2200/026Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • B01L2200/027Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0645Electrodes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406Moving fluids with specific forces or mechanical means specific forces capillary forces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0442Moving fluids with specific forces or mechanical means specific forces thermal energy, e.g. vaporisation, bubble jet

Definitions

  • Microfluidic systems may be used to perform a variety of cbemica!, biological, and biochemical processes, such as nucleic acid testing. Delivery of reagents to a process site may be accomplished in a variety of ways. In one type of system, reagents are drawn through microf!uidic channels by a downstream pump.
  • FIG. 1 Is a schematic diagram of an example system that uses droplet ejection to sequence flow of fluid through microfluidic networks.
  • FIG. 2 is a flowchart of an example method that uses droplet ejection to sequence flow of fluid through microfluidic networks.
  • FIG. 3 is a schematic diagram of an example system that uses input and output droplet ejection to sequence flow of fluid through microfluidic networks.
  • FIG. 4 is a control diagram of example input and output droplet ejection to sequence flow of fluid through microf!uidic networks.
  • FIG. 5 is a schematic diagram of an example system that uses a cartridge for droplet ejection to sequence flow of fluid through microfluidic networks.
  • FIG. 6 is a schematic diagram of an example system that uses sequenced input and output droplet ejection to perform a nucleic acid
  • FIG 7 is a flowchart of an example method that uses droplet ejection to sequence flow of fluid through microfluidic networks to perform a nucleic acid testing process.
  • Microfluidic systems often include a network of microfluidic channels.
  • Flow rates in a typical system are often interdependent. That is, fluid flow induced by a downstream pump that draws a reaction product from a channel where a reaction takes place often dictates upstream flow of the reagents into the channel. Changing flow rate through such a channel means that input flow rates of reagents are also changed.
  • the geometry of a microfluidic network, relative sizes of channels, and other factors may determine the interdependency of flow rates.
  • Fluid control components e.g., valves, pumps, etc.
  • valves, pumps, etc. are often provided to microfluidic channels to control flow rates that would otherwise be interdependent.
  • control elements add complexity.
  • droplet ejectors or arrays thereof are used to create negative pressure to draw a fluid, such as a reactant or intermediate reaction product, from a mesofluidic chamber to different downstream targets, such as
  • microfluidic networks for nucleic acid amplification. Flow through different downstream targets is decoupled.
  • Droplet ejectors or arrays thereof may also be used to provide input fluid to a mesofluidic chamber upstream of the targets.
  • the mesofluidic chamber may be used to mix, react, accumulate, concentrate, or perform other fluid manipulation on different inputted fluids. Input fluid flow is decoupled from flow though downstream targets
  • Fluid flow through different downstream targets may be sequenced according to the needs of an analytical process implemented input fluid flow may also be sequenced, so that suitable source fluid for downstream targets is generated
  • a wide variety of analytical processes such as nucleic acid testing processes, may thus be performed using controllably synchronized fluid flow without the need for valves or other mechanisms.
  • a device includes a non-transitory machine-readable medium including instructions that when executed by a processor cause the processor to control input of a fluid to a chamber that feeds a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector.
  • the instructions are further to cause the processor to sequence an ejection of droplets at the first droplet ejector and the second droplet ejector to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network.
  • the instructions are further to cause the processor to initiate an analytical process at the first and second target microfluidic networks.
  • the instructions can further sequence input flow of different fluids into the chamber at different times
  • the instructions can further sequence ejection of droplets at the first droplet ejector and the second droplet ejector based on the sequenced input flow of the different fluids.
  • the instructions can further delay ejection of droplets at the first droplet ejector and the second droplet ejector by a hold time of the fluid in the chamber or a determined volume of fluid in the chamber. [0020] The instructions can further initiate a nucieic acid testing process as the analytical process.
  • the instructions can further perform a first portion of a nucleic acid testing process at the first target microfluidic network and perform a second portion of the nucleic acid testing process at the second target microfluidic network.
  • the device can further include a processor and an interface electrically connected to the processor.
  • the processor is electrically connected to the non-transitory machine-readable medium.
  • the interface is to receive electrical connection of a removable cartridge.
  • the removable cartridge includes the chamber, the first channel, the first droplet ejector, the second channel, the second droplet ejector, the first target microfluidic network, and the second target microfluidic network.
  • the device can further include an input droplet ejector to provide the fluid to the chamber.
  • a device in some examples, includes a housing; a chamber at the housing; a first channel communicating with the chamber; a first target microfluidic network communicating with the first channel; a first droplet ejector at an end of the first channel; a second channel communicating with the chamber; a second target microfluidic network communicating with the second channel; a second droplet ejector at an end of the second channel; and a signal interface at the housing and electrically connected to the first and second droplet ejectors.
  • the chamber is to receive a fluid and the first target microfluidic network is to perform an analytical process with the fluid.
  • the second target microfluidic network is to cooperate with the first target microfluidic network to perform the analytical process.
  • the signal interface is to receive a signal to sequence ejection of droplets at the first and second droplet ejectors to draw the fluid through to first and second target microfluidic networks.
  • FIG 1 shows an example system 100 that uses droplet ejection to sequence flow of fluid through microfluidic networks to perform an analytical process, such as a nucleic acid testing process that uses nucleic acid amplification
  • the system 100 includes a chamber 102, a first microfluidic channel 104 in communication with the chamber 102, a second microfluidic channel 106 in communication with from the chamber 102, a first target microfluidic network 108 at the first channel 104, a second target microfluidic network 1 10 at the second channel 106, a first droplet ejector 1 12 positioned at the first channel 104, and a second droplet ejector 1 14 positioned at the second channel 106.
  • the chamber 102 is to receive and contain a fluid.
  • the chamber 102 is mesofluidic in scale relative to the channels 104, 106, target microfluidic networks 108, 1 10, and the droplet ejectors 1 12, 1 14, which are microfluidic in scale.
  • the chamber 102 may be provided with a fluid or a sequence of fluids. A sequence of fluids may be provided by controlling fluid flow into the chamber 102, by performing a reaction in the chamber 102, or by performing other fluid manipulation with the chamber 102
  • the chamber 102 may be vented to allow pressure equalization in the chamber 102 as fluid is moved into and out of the chamber 102.
  • the fluid provided to the chamber 102 may be a reagent, such as a chemical solution, a sample (e.g., a deoxyribonucleic acid or DNA sample, a ribonucleic acid or RNA sample, etc.), or other material.
  • a reagent such as a chemical solution, a sample (e.g., a deoxyribonucleic acid or DNA sample, a ribonucleic acid or RNA sample, etc.), or other material.
  • a reagent such as a chemical solution, a sample (e.g., a deoxyribonucleic acid or DNA sample, a ribonucleic acid or RNA sample, etc.), or other material.
  • a sample e.g., a deoxyribonucleic acid or DNA sample, a ribonucleic acid or RNA sample, etc.
  • solvent solutions e.g., alcohol-based solvent solutions
  • oil-based solutions e.g., oil-based
  • the first and second channels 104, 106 may originate at the chamber 102 or may branch from a common channel 122 that originates at the chamber 102. irrespective of the specific structure of the first and second channels 104, 106, the first and second channels 104, 106 are capable of communicating fluid from the chamber 102
  • the first channel 104 terminates at the first droplet ejector 1 12 and the second channel 108 terminates at the second droplet ejector 1 14
  • the channels 104, 106, 122 may be primed with fluid to communicate negative pressure from the droplet ejectors 1 12, 1 14 to the chamber 102.
  • the priming fluid may include a drive fluid that is not used by a process implemented by a target microfluidic network 108, 1 10 or a working fluid that is used by a target microfluidic network 108, 1 10.
  • a channel 104, 106, 122 may be preloaded with any number and sequence of slugs of drive and working fluids.
  • the first and second droplet ejectors 1 12, 1 14 may be formed at a substrate and such a substrate may have multiple layers.
  • the substrate may include silicon, glass, photoresist (e.g., SU-8), or similar materials.
  • a droplet ejector 1 12, 1 14 may include a jet element, such as a resistive heater, a piezoelectric element, or similar device that may implement inkjet droplet jetting techniques, such as thermal inkjet (TU) jetting.
  • the jet element is controllable to draw fluid from the respective channel 104, 106 to jet fluid droplets out an orifice.
  • An array having any number of droplet ejectors 1 12, 1 14 may be provided to a respective channel 104, 106.
  • the first droplet ejector 1 12 is positioned at the first channel 104 downstream of the first target microfluidic network 108.
  • the first droplet ejector 1 12 may be positioned at an end of the first channel 104, such that the first target microfluidic network 108 is between the chamber 102 and the first droplet ejector 1 12.
  • the first droplet ejector 1 12 draws fluid from the chamber 102 through the first channel 104 and into the first target microfluidic network 108 by low pressure generated by droplet ejection.
  • the first droplet ejector 1 12 may be fed by a fluid reservoir connected between the first channel 104 and the droplet ejector 1 12. Such a fluid reservoir may supply a volume of drive fluid to be ejected.
  • the second droplet ejector 1 14 is positioned at the second channel 106 downstream of the second target microfluidic network 1 10.
  • the second droplet ejector 1 14 may be positioned at an end of the second channel 106, such that the second target microf!uidic network 1 10 is between the chamber 102 and the second droplet ejector 1 14.
  • the second droplet ejector 1 14 draws fluid from the chamber 102 through the second channel 108 and into the second target microfluidic network 1 10 by low pressure generated by droplet ejection.
  • the second droplet ejector 1 14 may be fed by a fluid reservoir connected between the second channel 106 and the droplet ejector 1 14. Such a fluid reservoir may supply a volume of drive fluid to be ejected.
  • the first droplet ejector 1 12 may provide capillary action to resist backflow of fluid from the first channel 104 into the second channel 106. That is, when the second droplet ejector 1 14 is driven and the first droplet ejector 1 12 is not driven, resistance and counteracting capillary pressure at the first droplet ejector 1 12 due to capillary action may prevent fluid in the first channel 104 from being drawn back into the chamber 102 or into the second channel 106.
  • the second droplet ejector 1 14 may provide capillary action to resist backflow of fluid from the second channel 106.
  • a target microfluidic network 108, 1 10 may include a passive component, such as a network of microfluidic channels, which may be made of silicon, silicon oxide, photoresist, poiydimethy!si!oxane (ROMS), cyclic olefin copolymer (COC), other plastics, glass, or other materials that may be made using micro-fabrication technologies.
  • the target microfluidic network 108, 1 10 may contain a solid compound to interact with fluid delivered by the respective channel 104, 106.
  • a solid compound may be solid in bulk, may be a powder or particulate, may be integrated into a fibrous material, or similar.
  • a target microfluidic network 108, 1 10 may include an active component.
  • active components include a pump, sensor, mixing chamber, channel, heater, reaction chamber, droplet ejector, or similar component to perform further action on fluid delivered by the respective channel 104, 106.
  • a target microfluidic network 108, 1 10 includes microfluidic structure to implement a nucleic acid testing process, such as process that uses nucleic acid amplification (NAT), such as polymerase chain reaction (PCR), real-time or quantitative polymerase chain reaction (qPCR), reverse transcription polymerase chain reaction (RT-PCR), loop mediated isothermal amplification (LAMP), and similar.
  • NAT nucleic acid amplification
  • PCR polymerase chain reaction
  • qPCR real-time or quantitative polymerase chain reaction
  • RT-PCR reverse transcription polymerase chain reaction
  • LAMP loop mediated isothermal amplification
  • the system 100 further includes a processor 1 16 and memory 1 18 connected to the processor.
  • the processor 1 18 is connected to the droplet ejectors 1 12, 1 14 to provide a signal to sequence ejection of droplets by the droplet ejectors 1 12, 1 14.
  • the memory 1 18 stores flow sequencing instructions 120 to generate such a signal.
  • the processor 1 16 may include a centra! processing unit (CPU), a microcontroller, a microprocessor, a processing core, a field-programmable gate array (FPGA), or a similar device capable of executing instructions.
  • the processor 1 16 cooperates with the memory 1 18, which includes a non-transitory machine-readable medium that may be an electronic, magnetic, optical, or other physical storage device that encodes executable instructions.
  • the machine- readable medium may include, for example, random access memory (RAM), read-only memory (ROM), eiectrically-erasable programmable read-only memory (EEPROM), flash memory, a storage drive, an optical disc, or similar.
  • the flow sequencing instructions 120 are to sequence ejection of fluid droplets at the first droplet ejector 1 12 and the second droplet ejector 1 14 to induce negative pressure to provide a sequenced output flow of the fluid through the first channel 104 to the first target microfluidic network 108 and through the second channel 106 to the second target microfluidic network 1 10.
  • the sequencing of droplet ejection allows the first and second target microfluidic networks 108, 1 10 to perform an analytical process with a sequenced delivery of fluid.
  • the processor 1 16 may further control the first and second target microfluidic networks 108, 1 10 to perform the analytical process, such as by controlling a heater or other active component at a microfluidic network 108, 1 10. Control of a heater may include performing temperature cycling of a PCR process or other nucleic acid amplification process.
  • the processor 1 16 may be connected to the target microfluidic networks 108, 1 10 to initiate the process, control the process, or allow information to be shared between the target microfluidic networks 108, 1 10 and with the processor 1 16.
  • the instructions 120 may initiate a nucleic acid testing process at the target microfluidic networks 108, 1 10 after or during sequenced ejection of fluid at the droplet ejectors 1 12, 1 14. Further, a parameter of a subsequent process to be performed at a target microfluidic network 108, 1 10 may be adjusted based on final or intermediate results from a process performed at a target microfluidic network 108, 1 10. That is, feedback may be shared among different target microfluidic networks 108, 1 10.
  • fluid provided to the chamber 102 may include, for example, a DNA/RNA sample, a lysis buffer, washing solution, an elution buffer, a PCR master mix, and similar. Fluid may be provided to the chamber 102 in a time-controlled manner, so that desired fluid may be drawn into each target microfluidic network 108, 1 10.
  • a nucleic acid testing process may be divided into a plurality of portions that may be performed in parallel. For example, a first portion of a nucleic acid testing process may be performed at the first target microfluidic network 108 and a second portion of the nucleic acid testing process may be performed at the second target microfluidic network 1 10. Information from one portion of the process may be shared with another portion of the process via, for example, the processor 1 16.
  • Different nucleic acid testing processes may be performed by the target microfluidic networks 108, 1 10 and such processes may differ by virtue of a different reagent, different reagent concentration, different DNA/RNA sample, or the like.
  • Fluid movement through system 100 may be controlled by the droplet ejectors 1 12, 1 14 without the need for other active components, such as valves, for isolation of fluid having different properties or contents. Further, back flow of fluid from one channel 104, 106 to another channel 104, 106 may be prevented by capillary resistance provided by the droplet ejectors 1 12, 1 14 As such, a subprocess may be performed at each target microfluidic networks 108, 1 10 with an expected fluid that may be generated within the mesofiuidic chamber 102.
  • the devices and systems described herein can be used with a method for sequencing flow of fluid through target microfluidic networks.
  • An example method includes providing fluid to a chamber. The chamber feeds a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector. The method further includes sequencing ejection of droplets at the first droplet ejector and the second droplet ejector to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network. The method further includes controlling the first and second target microfluidic networks to perform an analytical process with the fluid.
  • the method can include providing different fluids to the chamber according to a sequenced input flow, in which different fluids are introduced to the chamber at different times.
  • the method can further include sequencing ejection of droplets at the first droplet ejector and the second droplet ejector based on the sequenced input flow of the different fluids.
  • the method can further include ejecting the different fluids into the chamber using different droplet ejectors.
  • the method can further include sequencing ejection of droplets at the first droplet ejector and the second droplet ejector based on a hold time of the fluid in the chamber.
  • the method can further include performing a first portion of a nucleic acid testing process at the first target microfluidic network and performing a second portion of the nucleic acid testing process at the second target microfluidic network.
  • FIG. 2 shows an example method 200 of droplet ejection to sequence flow of fluid through target microfluidic networks.
  • the method 200 may be performed by any of the systems and devices described herein.
  • the method starts at block 202.
  • fluid is provided to a mesofluidic chamber that communicates with a plurality of target microfluidic networks.
  • fluid may be ejected into the chamber by a droplet ejector. Mixing, reacting, accumulating, or other fluid manipulation may be performed on fluid within the chamber.
  • fluid is ejected in a sequenced manner from droplet ejectors positioned downstream of the target microfluidic networks to induce a sequenced output flow of fluid from the chamber, through respective channels, and into the target microfluidic networks.
  • Droplet ejection draws fluid from the chamber into a target microfluidic network by inducing negative pressure downstream of the target microfiuidic network.
  • the ejection sequence may be selected to bring fluid into each microfiuidic network at the appropriate time for cooperative performance of an analytical process by the target microfiuidic networks.
  • the ejection sequence may be selected to perform multiple different analytical processes in different target microfiuidic networks in a parallel and time-efficient manner.
  • the target microfiuidic networks are controlled to perform an analytical process with the sequenced delivery of fluid.
  • the target microfiuidic networks may cooperate, perform parallel subprocesses, perform independent processes, or function according to another methodology. Control may be effected by the fluid flowing through the target microfiuidic networks, and hence, determined by the ejection of droplets at the droplet ejectors.
  • Control may also or alternatively be effected by processor, which may also control the droplet ejectors.
  • processor may directly control active components of the target microfluidic networks
  • FIG. 3 shows an example system 300. Additional features and aspects of the other devices and systems described herein may be used with the system 300 and vice versa. Like reference numerals denote like elements and description of like elements is not repeated here.
  • the system 300 includes a plurality of source fluid reservoirs 302, 304 to feed different fluids to a mesofluidic chamber 102 that feeds fluid to a plurality of microfluidic networks 108, 1 10.
  • Fluid may be provided to the chamber 102 by droplet ejectors 306,
  • fluid may be ejected into the chamber 102 to accumulate, mix, react, be
  • the system 300 may include downstream fluid reservoirs 312, 314.
  • a first fluid reservoir 312 may communicate the first channel 104 to the first droplet ejector 1 12 and may supply a volume of drive fluid to be ejected by the first droplet ejector 1 12.
  • a second fluid reservoir 314 may communicate the second channel 106 to the second droplet ejector 1 14 and may supply a volume of drive fluid to be ejected by the second droplet ejector 1 14.
  • Processor-executable flow sequencing instructions 310 may provide different fluids to the chamber 102 with the input droplet ejectors 306, 308 according to a sequenced input flow. That is, different fluids may be introduced to the chamber 102 at different times by the different input droplet ejectors 306, 308. Sequenced input flow may be controlled according to the accumulating, mixing, reaction, concentrating, or other manipulation performed at the chamber 102
  • the processor-executable flow sequencing instructions 310 may further effect sequenced ejection of droplets at the downstream droplet ejectors 1 12, 1 14 based on the sequenced input flow of the different fluids into the chamber 102. That is, a sequence followed to draw fluid into the microfiuidic networks 108, 1 10 may be based on the sequenced generation of the fluid at the chamber 102 using the input droplet ejectors 306, 308. Input and output flow may be coordinated.
  • the processor-executable flow sequencing instructions 310 may sequence ejection of droplets at the downstream droplet ejectors 1 12, 1 14 based on a hold time of fluid in the chamber 102.
  • a hold time may be used to allow mixing, concentrating, reacting, or similar manipulation to complete.
  • activation of the downstream droplet ejectors 1 12, 1 14 may be delayed so that a suitable fluid is generated at the chamber 102 prior to such fluid being drawn through the target microfiuidic networks 108, 1 10.
  • the processor-executable flow sequencing instructions 310 may sequence ejection of droplets at the downstream droplet ejectors 1 12, 1 14 based on a volume of fluid in the chamber 102.
  • Volume may be computed from droplet ejection rate into the chamber 102 That is, a volumetric flow rate of input droplet ejectors 306, 308 may be stored in memory for reference by the instructions 310.
  • a correlation of volumetric flow rates, such as a lookup table or function, may be provided for different ejection frequencies.
  • sensor 320 may be connected to the processor 1 16 and may be provide at the chamber 102. For example, sensing electrodes may be provided to the chamber 102 to determine volume of fluid in the chamber 102. Other types of sensors, such as inductive sensors, may be used.
  • a downstream droplet ejector 1 12, 114 may be activated when a particular volume of fluid is determined to be present in the chamber 102
  • flow sequencing instructions 310 may control input droplet ejection rates 400, 402 of any number of droplet ejectors positioned provide different fluids to a mesofluidic chamber 102. Each fluid may be fed info the chamber 102 at a specific flow rate that may be controlled by a frequency of droplet ejection and a quantity of droplet ejection nozzles that are activated.
  • input droplet ejection rates 400, 402 may be varied over time to provide a specific fluid at the chamber 102 As such, fluid may be mixed, reacted, accumulated, concentrated, or otherwise generated in the chamber 102. Such fluid may then be selectively provided to target microfluidic networks 108, 1 10 positioned downstream of the chamber 102.
  • the flow sequencing instructions 310 may further control output droplet ejection rates 404, 406 of any number of droplet ejectors positioned downstream of the target microfluidic networks 108, 1 10 to draw selected fluid into the target microfluidic networks 108, 1 10. That is, when the chamber 102 contains a specific fluid that is intended for a specific target microfluidic network 108, 1 10, then the respective droplet ejection rate 404, 406 is controlled to draw the specific fluid into the specific target microfluidic network 108, 1 10 at a specific flow rate.
  • the specific flow rate may be controlled by a frequency of droplet ejection and a quantity of droplet ejection nozzles that are activated. At the same time, other droplet ejection rates 404, 406 may be controlled to stop.
  • An increase to an output droplet ejection rate 404, 406 may be controlled to lag an increase to an input droplet ejection rate 400, 402 and such delay in movement of fluid from the chamber 102 may be used to implement a dwell time, to allow a reaction sufficient time to perform, or for a similar purpose
  • the chamber 102 acts as a mesofluidic interface between the input microfluid flow and output microfluidic flow. As such, the chamber 102 reduces complexity for mixing, reaction, or other fluid manipulation process that would otherwise require increased complexity to implement at the microfluidic scale.
  • FIG. 5 shows an example system 500.
  • FIG. 5 shows an example system 500.
  • Features and aspects of the other devices and systems described herein may be used with the system 500 and vice versa.
  • Like reference numerals denote like elements and description of like elements is not repeated here.
  • the system 500 includes a cartridge 502 including plurality of input droplet ejectors 308, 308 that dispense different fluids to a mesof!uidic chamber 102, a plurality of target microfluidic networks 108, 1 10 in fluid communication with the chamber 102, and a plurality of output droplet ejectors 1 12, 1 14 that induce negative pressure to draw fluid from the chamber 102 into the target microfluidic networks 108, 1 10.
  • Such components may be contained within a cartridge housing 504.
  • the cartridge 502 further includes a signal interface 506 at the housing 504.
  • the signal interface 506 is electrically connected to the droplet ejectors 306, 308, 1 12, 1 14 to receive a signal to sequence ejection of droplets to provide fluid to the chamber 102 and draw the fluid through target microfluidic networks 108, 1 10
  • the signal interface 506 may include an electrical contact.
  • the system 500 further includes an analysis device 508.
  • the analysis device 508 includes a memory 1 18 and processor 1 16.
  • the memory 1 18 may store flow sequencing instructions 310 for execution by the processor 1 16.
  • the processor 1 16 is connected to an interface 510 that may include an electrical contact.
  • the interface 510 provides for communications with the processor 1 16.
  • the cartridge 502 is removably mechanically connected to the analysis device 508.
  • the signal interface 506 of the cartridge 502 electrically connects to the interface 510 of the analysis device 508, so that the processor 1 16 may control the droplet ejectors 306, 308, 1 12, 1 14 and the target microfluidic networks 108, 1 10 according to the flow sequencing instructions 310.
  • the resulting information may be communicated to the memory 1 18 or otheavise outputted and the cartridge 502 may be disconnected from the analysis device 508 and discarded.
  • FIG. 6 shows an example system 600 for a nucleic acid testing process.
  • FIG. 6 shows an example system 600 for a nucleic acid testing process.
  • Features and aspects of the other devices and systems described herein may be used with the system 600 and vice versa.
  • Like reference numerals denote like elements and description of like elements is not repeated here.
  • the system 600 includes a plurality of fluid ejection units 602 positioned to dispense fluid into a mesofluidic chamber 604.
  • Each ejection unit includes a fluid reservoir 606, which may be pre!oaded or loaded at time of use, and an array of droplet ejectors 608.
  • Different fluid ejection units 602 may provide different fluids to the mesofluidic chamber 604.
  • the chamber 604 may be funnel shaped to direct input fluid received from the fluid ejection units 602 to a fluid outlet that feeds a network of microfluidic channels 610.
  • the chamber 604 includes a vent 612 to allow individual channels of the network of microfluidic channels 610 to function independently.
  • a magnet 626, filter, or similar component that may be positioned near the outlet of the chamber 604 to interact with fluid in the chamber 604. in other examples, a magnet may be embedded in or attached to an inner wall of the funnel wall of the chamber 604. As such, a reagent may be made to contact or not contact the magnet, depending on relative positions of the magnet and the fluid ejection units 602. For example, magnetic material may be placed in the path of ejection of a particular fluid ejection unit 602 and outside a path of ejection of another fluid ejection unit 602.
  • the network of microfluidic channels 610 is communicates the chamber with first and second target microfluidic networks 108, 1 10 via first and second channels 614, 618 that terminate a respective first and second droplet ejectors 1 12, 1 14. Ejection of droplets at a droplet ejector 1 12, 1 14 induces a negative pressure that draws fluid from the chamber 604 through the respective target microfluidic network 108, 1 10.
  • the network of microfiuidic channels 610 may further include a third channel 620 that feeds a waste droplet ejector 622 that serves to clear fluid from the chamber 604 without flowing through a target microfiuidic network 108, 1 10.
  • the waste droplet ejector 622 may connect with the third channel 620 via a fluid reservoir 628 that may be loaded with drive fluid.
  • Ail output droplet ejectors 1 12, 1 14, 622 may eject to waste.
  • a processor 1 16 is connected to the droplet ejectors 608, 1 12, 1 14, 622 and activates the droplet ejectors 608, 1 12, 1 14, 622 based on flow sequencing instructions 624 that may be stored in a memory 1 18.
  • Fluid ejection units 602 may be provided for a wash buffer, an elution buffer, and a fluid containing a DNA/RNA sample.
  • the flow sequencing instructions 624 may activate respective droplet ejectors to introduce the sample and wash buffer to the mesofluidic chamber 604 and draw resulting waste product through the waste channel 620.
  • Sample material may be retained in the chamber 604 by a magnet 626, filter, or similar component that may be positioned near the outlet of the chamber 604.
  • the flow sequencing instructions 624 may activate respective droplet ejectors to introduce elution buffer to the mesofluidic chamber 604 to elute the sample material and flow the resulting product through the first target microfiuidic network 108.
  • a nucleic acid application process may then be initiated at the first target microfiuidic network 108.
  • Fluid containing another sample may be ejected into the chamber 604 and the washing and elution processes may be repeated with resulting fluid being draw info the second target microfiuidic network 1 10, so that many nucleic acid application processes may be performed in a parallel staged manner using a plurality of target microfiuidic networks 108, 1 10.
  • An outcome of a test performed by a target microfiuidic network 108 may be used to modify parameters of a subsequent test performed by the next target microf!uidic network 1 10. For example, a low signal from a first DNA/RNA sample may be used to increase elution of a second DNA/RNA sample.
  • FIG. 7 shows an example method 700 of droplet ejection to sequence flow of fluid through target microfluidic networks to perform a nucleic acid testing process.
  • the method 700 may be performed by any of the systems and devices described herein, such as the system 600 which will be referenced as an example.
  • the method starts at block 702.
  • fluid is provided to a chamber that feeds a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector.
  • Different fluids may be provided to the chamber according to a sequenced input flow, in which different fluids are introduced to the chamber at different times.
  • Different fluids may be inputted into the chamber by ejecting the different fluids into the chamber using different input droplet ejectors.
  • different input fluid ejection units 602 may be provided with a wash buffer, an elution buffer, and a fluid containing a DNA/RNA sample, and droplets of these fluids may be ejected into the chamber 604 at different times.
  • ejection of droplets at the first droplet ejector and the second droplet ejector, located downstream of the chamber may be sequenced to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network.
  • the sequencing of ejection of droplets at the first droplet ejector and the second droplet ejector may occur after a hold time of fluid in the chamber. That is, input fluid may be allowed time to mix, react, concentrate, accumulate, or undergo other fluid manipulation prior to fluid being drawn from the chamber.
  • the sequencing of ejection of droplets at the first droplet ejector and the second droplet ejector may be based on the sequenced input flow of the different fluids into the chamber. That is, a plurality of DNA/RNA samples may be provided to the chamber at different times. For example, a first DNA/RNA sample ejected info the chamber 604, after washing and elution, may be drawn from the chamber 604 to the first target microfluidic network 108 by activation of the first droplet ejector 1 12.
  • a second DNA/RNA sample ejected into the chamber 604 may be drawn from the chamber 604 to the second target microf!uidic network 1 10 by activation of the second droplet ejector 1 14.
  • the first and second target microfluidic networks are controlled to perform an analytical process with fluid provided by action of the first and second droplet ejectors.
  • a PCR process may be performed by controlling a heater to temperature cycle fluid containing a
  • a first portion of a nucleic acid testing process may be performed at the first target microfluidic network and a second portion of the nucleic acid testing process may be performed at the second target microfluidic network.
  • each of a plurality of working DNA/RNA samples provided to the chamber 604 in sequence may be drawn into the respective target microfluidic network 108, 1 10 in sequence to perform a plurality of PCR processes in a time-staggered and parallel manner.
  • the plurality of working DNA'RNA samples are contemplated to be from the same origin to avoid contamination.
  • an ejection unit 602 may be loaded with an original DNA/RNA sample that is to be analyzed by sequenced dispensing of working samples into the chamber 102. Samples may differ in concentration, preparation (e.g., isolation, washing, elution, etc.), or other parameter.
  • the method 700 may be repeated for different input fluids, different input fluid sequences, different fluid manipulations in the chamber, different output fluid sequences, or different operations of a target microfluidic network, via block 710.
  • the method 700 then ends at block 712.
  • droplet ejectors or arrays thereof are used to input fluid to a mesofluidic chamber and draw fluid from the mesofluidic chamber according to a controllable sequence.
  • Different fluid flow paths through different downstream targets may be decoupled from each other and further may be decoupled from flow paths into the mesofluidic chamber.
  • the mesofluidic chamber may be used to mix, react, accumulate, concentrate, or perform other fluid manipulation on different inputted fluids.
  • Input fluid flow and fluid flow through different downstream targets may be sequenced according to the needs of an analytical process implemented, such as a nucleic acid testing process.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

An example method includes providing fluid to a chamber. The chamber feeds a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector. The method further includes sequencing ejection of droplets at the first droplet ejector and the second droplet ejector to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network, and controlling the first and second target microfluidic networks to perform an analytical process with the fluid.

Description

SEQUENCED DROPLET EJECTION TO DELIVER FLUIDS BACKGROUND
[0001 ] Microfluidic systems may be used to perform a variety of cbemica!, biological, and biochemical processes, such as nucleic acid testing. Delivery of reagents to a process site may be accomplished in a variety of ways. In one type of system, reagents are drawn through microf!uidic channels by a downstream pump.
BRIEF DESCRIPTION OF THE DRAWINGS
[0002] FIG. 1 Is a schematic diagram of an example system that uses droplet ejection to sequence flow of fluid through microfluidic networks.
[0003] FIG. 2 is a flowchart of an example method that uses droplet ejection to sequence flow of fluid through microfluidic networks.
[0004] FIG. 3 is a schematic diagram of an example system that uses input and output droplet ejection to sequence flow of fluid through microfluidic networks.
[0005] FIG. 4 is a control diagram of example input and output droplet ejection to sequence flow of fluid through microf!uidic networks.
[0008] FIG. 5 is a schematic diagram of an example system that uses a cartridge for droplet ejection to sequence flow of fluid through microfluidic networks.
[0007] FIG. 6 is a schematic diagram of an example system that uses sequenced input and output droplet ejection to perform a nucleic acid
amplification process. [0008] FIG 7 is a flowchart of an example method that uses droplet ejection to sequence flow of fluid through microfluidic networks to perform a nucleic acid testing process.
DETAILED DESCRIPTION
[0009] Microfluidic systems often include a network of microfluidic channels. Flow rates in a typical system are often interdependent. That is, fluid flow induced by a downstream pump that draws a reaction product from a channel where a reaction takes place often dictates upstream flow of the reagents into the channel. Changing flow rate through such a channel means that input flow rates of reagents are also changed. The geometry of a microfluidic network, relative sizes of channels, and other factors may determine the interdependency of flow rates.
[0010] The same interdependency applies to parallel microfluidic networks that receive fluid from a common source. Changing a flow rate in one network often affects a flow rate in another network.
[001 1 ] Fluid control components (e.g., valves, pumps, etc.) are often provided to microfluidic channels to control flow rates that would otherwise be interdependent. However, such control elements add complexity.
[0012] To reduce the need for such fluid control components and provide for simplified control of a microfluidic analyticai process, such as a nucleic acid testing process, droplet ejectors or arrays thereof are used to create negative pressure to draw a fluid, such as a reactant or intermediate reaction product, from a mesofluidic chamber to different downstream targets, such as
microfluidic networks for nucleic acid amplification. Flow through different downstream targets is decoupled.
[0013] Droplet ejectors or arrays thereof may also be used to provide input fluid to a mesofluidic chamber upstream of the targets. The mesofluidic chamber may be used to mix, react, accumulate, concentrate, or perform other fluid manipulation on different inputted fluids. Input fluid flow is decoupled from flow though downstream targets
[0014] Fluid flow through different downstream targets may be sequenced according to the needs of an analytical process implemented input fluid flow may also be sequenced, so that suitable source fluid for downstream targets is generated
[0015] A wide variety of analytical processes, such as nucleic acid testing processes, may thus be performed using controllably synchronized fluid flow without the need for valves or other mechanisms.
[0018] in the examples, a device includes a non-transitory machine-readable medium including instructions that when executed by a processor cause the processor to control input of a fluid to a chamber that feeds a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector. The instructions are further to cause the processor to sequence an ejection of droplets at the first droplet ejector and the second droplet ejector to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network. The instructions are further to cause the processor to initiate an analytical process at the first and second target microfluidic networks.
[0017] The instructions can further sequence input flow of different fluids into the chamber at different times
[0018] The instructions can further sequence ejection of droplets at the first droplet ejector and the second droplet ejector based on the sequenced input flow of the different fluids.
[0019] The instructions can further delay ejection of droplets at the first droplet ejector and the second droplet ejector by a hold time of the fluid in the chamber or a determined volume of fluid in the chamber. [0020] The instructions can further initiate a nucieic acid testing process as the analytical process.
[0021 ] The instructions can further perform a first portion of a nucleic acid testing process at the first target microfluidic network and perform a second portion of the nucleic acid testing process at the second target microfluidic network.
[0022] The device can further include a processor and an interface electrically connected to the processor. The processor is electrically connected to the non-transitory machine-readable medium. The interface is to receive electrical connection of a removable cartridge. The removable cartridge includes the chamber, the first channel, the first droplet ejector, the second channel, the second droplet ejector, the first target microfluidic network, and the second target microfluidic network.
[0023] The device can further include an input droplet ejector to provide the fluid to the chamber.
[0024] in some examples, a device includes a housing; a chamber at the housing; a first channel communicating with the chamber; a first target microfluidic network communicating with the first channel; a first droplet ejector at an end of the first channel; a second channel communicating with the chamber; a second target microfluidic network communicating with the second channel; a second droplet ejector at an end of the second channel; and a signal interface at the housing and electrically connected to the first and second droplet ejectors. The chamber is to receive a fluid and the first target microfluidic network is to perform an analytical process with the fluid. The second target microfluidic network is to cooperate with the first target microfluidic network to perform the analytical process. The signal interface is to receive a signal to sequence ejection of droplets at the first and second droplet ejectors to draw the fluid through to first and second target microfluidic networks. [0025] FIG 1 shows an example system 100 that uses droplet ejection to sequence flow of fluid through microfluidic networks to perform an analytical process, such as a nucleic acid testing process that uses nucleic acid amplification
[0026] The system 100 includes a chamber 102, a first microfluidic channel 104 in communication with the chamber 102, a second microfluidic channel 106 in communication with from the chamber 102, a first target microfluidic network 108 at the first channel 104, a second target microfluidic network 1 10 at the second channel 106, a first droplet ejector 1 12 positioned at the first channel 104, and a second droplet ejector 1 14 positioned at the second channel 106.
[0027] The chamber 102 is to receive and contain a fluid. The chamber 102 is mesofluidic in scale relative to the channels 104, 106, target microfluidic networks 108, 1 10, and the droplet ejectors 1 12, 1 14, which are microfluidic in scale. The chamber 102 may be provided with a fluid or a sequence of fluids. A sequence of fluids may be provided by controlling fluid flow into the chamber 102, by performing a reaction in the chamber 102, or by performing other fluid manipulation with the chamber 102 The chamber 102 may be vented to allow pressure equalization in the chamber 102 as fluid is moved into and out of the chamber 102.
[0028] The fluid provided to the chamber 102 may be a reagent, such as a chemical solution, a sample (e.g., a deoxyribonucleic acid or DNA sample, a ribonucleic acid or RNA sample, etc.), or other material. The term“fluid” is used herein to denote a material that may be jetted, such as aqueous solutions, suspensions, solvent solutions (e.g., alcohol-based solvent solutions), oil-based solutions, or other materials
[0029] The first and second channels 104, 106 may originate at the chamber 102 or may branch from a common channel 122 that originates at the chamber 102. irrespective of the specific structure of the first and second channels 104, 106, the first and second channels 104, 106 are capable of communicating fluid from the chamber 102 The first channel 104 terminates at the first droplet ejector 1 12 and the second channel 108 terminates at the second droplet ejector 1 14
[0030] The channels 104, 106, 122 may be primed with fluid to communicate negative pressure from the droplet ejectors 1 12, 1 14 to the chamber 102. The priming fluid may include a drive fluid that is not used by a process implemented by a target microfluidic network 108, 1 10 or a working fluid that is used by a target microfluidic network 108, 1 10. A channel 104, 106, 122 may be preloaded with any number and sequence of slugs of drive and working fluids.
[0031 ] The first and second droplet ejectors 1 12, 1 14 may be formed at a substrate and such a substrate may have multiple layers. The substrate may include silicon, glass, photoresist (e.g., SU-8), or similar materials. A droplet ejector 1 12, 1 14 may include a jet element, such as a resistive heater, a piezoelectric element, or similar device that may implement inkjet droplet jetting techniques, such as thermal inkjet (TU) jetting. The jet element is controllable to draw fluid from the respective channel 104, 106 to jet fluid droplets out an orifice. An array having any number of droplet ejectors 1 12, 1 14 may be provided to a respective channel 104, 106.
[0032] The first droplet ejector 1 12 is positioned at the first channel 104 downstream of the first target microfluidic network 108. The first droplet ejector 1 12 may be positioned at an end of the first channel 104, such that the first target microfluidic network 108 is between the chamber 102 and the first droplet ejector 1 12. When driven, the first droplet ejector 1 12 draws fluid from the chamber 102 through the first channel 104 and into the first target microfluidic network 108 by low pressure generated by droplet ejection. The first droplet ejector 1 12 may be fed by a fluid reservoir connected between the first channel 104 and the droplet ejector 1 12. Such a fluid reservoir may supply a volume of drive fluid to be ejected.
[0033] The second droplet ejector 1 14 is positioned at the second channel 106 downstream of the second target microfluidic network 1 10. The second droplet ejector 1 14 may be positioned at an end of the second channel 106, such that the second target microf!uidic network 1 10 is between the chamber 102 and the second droplet ejector 1 14. When driven, the second droplet ejector 1 14 draws fluid from the chamber 102 through the second channel 108 and into the second target microfluidic network 1 10 by low pressure generated by droplet ejection. The second droplet ejector 1 14 may be fed by a fluid reservoir connected between the second channel 106 and the droplet ejector 1 14. Such a fluid reservoir may supply a volume of drive fluid to be ejected.
[0034] The first droplet ejector 1 12 may provide capillary action to resist backflow of fluid from the first channel 104 into the second channel 106. That is, when the second droplet ejector 1 14 is driven and the first droplet ejector 1 12 is not driven, resistance and counteracting capillary pressure at the first droplet ejector 1 12 due to capillary action may prevent fluid in the first channel 104 from being drawn back into the chamber 102 or into the second channel 106.
Likewise, the second droplet ejector 1 14 may provide capillary action to resist backflow of fluid from the second channel 106.
[0035] A target microfluidic network 108, 1 10 may include a passive component, such as a network of microfluidic channels, which may be made of silicon, silicon oxide, photoresist, poiydimethy!si!oxane (ROMS), cyclic olefin copolymer (COC), other plastics, glass, or other materials that may be made using micro-fabrication technologies. The target microfluidic network 108, 1 10 may contain a solid compound to interact with fluid delivered by the respective channel 104, 106. A solid compound may be solid in bulk, may be a powder or particulate, may be integrated into a fibrous material, or similar.
[0036] A target microfluidic network 108, 1 10 may include an active component. Examples of active components include a pump, sensor, mixing chamber, channel, heater, reaction chamber, droplet ejector, or similar component to perform further action on fluid delivered by the respective channel 104, 106.
[0037] in various examples, a target microfluidic network 108, 1 10 includes microfluidic structure to implement a nucleic acid testing process, such as process that uses nucleic acid amplification (NAT), such as polymerase chain reaction (PCR), real-time or quantitative polymerase chain reaction (qPCR), reverse transcription polymerase chain reaction (RT-PCR), loop mediated isothermal amplification (LAMP), and similar.
[0038] The system 100 further includes a processor 1 16 and memory 1 18 connected to the processor. The processor 1 18 is connected to the droplet ejectors 1 12, 1 14 to provide a signal to sequence ejection of droplets by the droplet ejectors 1 12, 1 14. The memory 1 18 stores flow sequencing instructions 120 to generate such a signal.
[0039] The processor 1 16 may include a centra! processing unit (CPU), a microcontroller, a microprocessor, a processing core, a field-programmable gate array (FPGA), or a similar device capable of executing instructions. The processor 1 16 cooperates with the memory 1 18, which includes a non-transitory machine-readable medium that may be an electronic, magnetic, optical, or other physical storage device that encodes executable instructions. The machine- readable medium may include, for example, random access memory (RAM), read-only memory (ROM), eiectrically-erasable programmable read-only memory (EEPROM), flash memory, a storage drive, an optical disc, or similar.
[0040] The flow sequencing instructions 120 are to sequence ejection of fluid droplets at the first droplet ejector 1 12 and the second droplet ejector 1 14 to induce negative pressure to provide a sequenced output flow of the fluid through the first channel 104 to the first target microfluidic network 108 and through the second channel 106 to the second target microfluidic network 1 10.
[0041 ] The sequencing of droplet ejection allows the first and second target microfluidic networks 108, 1 10 to perform an analytical process with a sequenced delivery of fluid. The processor 1 16 may further control the first and second target microfluidic networks 108, 1 10 to perform the analytical process, such as by controlling a heater or other active component at a microfluidic network 108, 1 10. Control of a heater may include performing temperature cycling of a PCR process or other nucleic acid amplification process. [0042] The processor 1 16 may be connected to the target microfluidic networks 108, 1 10 to initiate the process, control the process, or allow information to be shared between the target microfluidic networks 108, 1 10 and with the processor 1 16. For example, the instructions 120 may initiate a nucleic acid testing process at the target microfluidic networks 108, 1 10 after or during sequenced ejection of fluid at the droplet ejectors 1 12, 1 14. Further, a parameter of a subsequent process to be performed at a target microfluidic network 108, 1 10 may be adjusted based on final or intermediate results from a process performed at a target microfluidic network 108, 1 10. That is, feedback may be shared among different target microfluidic networks 108, 1 10.
[0043] In an example nucleic acid testing process, fluid provided to the chamber 102 may include, for example, a DNA/RNA sample, a lysis buffer, washing solution, an elution buffer, a PCR master mix, and similar. Fluid may be provided to the chamber 102 in a time-controlled manner, so that desired fluid may be drawn into each target microfluidic network 108, 1 10.
[0044] A nucleic acid testing process may be divided into a plurality of portions that may be performed in parallel. For example, a first portion of a nucleic acid testing process may be performed at the first target microfluidic network 108 and a second portion of the nucleic acid testing process may be performed at the second target microfluidic network 1 10. Information from one portion of the process may be shared with another portion of the process via, for example, the processor 1 16.
[0045] Different nucleic acid testing processes may be performed by the target microfluidic networks 108, 1 10 and such processes may differ by virtue of a different reagent, different reagent concentration, different DNA/RNA sample, or the like.
[0046] Fluid movement through system 100 may be controlled by the droplet ejectors 1 12, 1 14 without the need for other active components, such as valves, for isolation of fluid having different properties or contents. Further, back flow of fluid from one channel 104, 106 to another channel 104, 106 may be prevented by capillary resistance provided by the droplet ejectors 1 12, 1 14 As such, a subprocess may be performed at each target microfluidic networks 108, 1 10 with an expected fluid that may be generated within the mesofiuidic chamber 102.
[0047] In some examples, the devices and systems described herein can be used with a method for sequencing flow of fluid through target microfluidic networks. An example method includes providing fluid to a chamber. The chamber feeds a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector. The method further includes sequencing ejection of droplets at the first droplet ejector and the second droplet ejector to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network. The method further includes controlling the first and second target microfluidic networks to perform an analytical process with the fluid.
[0048] The method can include providing different fluids to the chamber according to a sequenced input flow, in which different fluids are introduced to the chamber at different times.
[0049] The method can further include sequencing ejection of droplets at the first droplet ejector and the second droplet ejector based on the sequenced input flow of the different fluids.
[0050] The method can further include ejecting the different fluids into the chamber using different droplet ejectors.
[0051 ] The method can further include sequencing ejection of droplets at the first droplet ejector and the second droplet ejector based on a hold time of the fluid in the chamber.
[0052] The method can further include performing a first portion of a nucleic acid testing process at the first target microfluidic network and performing a second portion of the nucleic acid testing process at the second target microfluidic network.
[0053] FIG. 2 shows an example method 200 of droplet ejection to sequence flow of fluid through target microfluidic networks. The method 200 may be performed by any of the systems and devices described herein. The method starts at block 202.
[0054] At block 204, fluid is provided to a mesofluidic chamber that communicates with a plurality of target microfluidic networks. For example, fluid may be ejected into the chamber by a droplet ejector. Mixing, reacting, accumulating, or other fluid manipulation may be performed on fluid within the chamber.
[0055] Next, at block 206, fluid is ejected in a sequenced manner from droplet ejectors positioned downstream of the target microfluidic networks to induce a sequenced output flow of fluid from the chamber, through respective channels, and into the target microfluidic networks. Droplet ejection draws fluid from the chamber into a target microfluidic network by inducing negative pressure downstream of the target microfiuidic network. The ejection sequence may be selected to bring fluid into each microfiuidic network at the appropriate time for cooperative performance of an analytical process by the target microfiuidic networks. The ejection sequence may be selected to perform multiple different analytical processes in different target microfiuidic networks in a parallel and time-efficient manner.
[0056] At block 208, the target microfiuidic networks are controlled to perform an analytical process with the sequenced delivery of fluid. The target microfiuidic networks may cooperate, perform parallel subprocesses, perform independent processes, or function according to another methodology. Control may be effected by the fluid flowing through the target microfiuidic networks, and hence, determined by the ejection of droplets at the droplet ejectors.
Control may also or alternatively be effected by processor, which may also control the droplet ejectors. Such a processor may directly control active components of the target microfluidic networks
[0057] Once the analytical process is complete, at block 210, the method ends, at block 212.
[0058] FIG. 3 shows an example system 300. Features and aspects of the other devices and systems described herein may be used with the system 300 and vice versa. Like reference numerals denote like elements and description of like elements is not repeated here.
[0059] The system 300 includes a plurality of source fluid reservoirs 302, 304 to feed different fluids to a mesofluidic chamber 102 that feeds fluid to a plurality of microfluidic networks 108, 1 10.
[0060] Fluid may be provided to the chamber 102 by droplet ejectors 306,
308 in communication with respective fluid reservoirs 302, 304. That is, fluid may be ejected into the chamber 102 to accumulate, mix, react, be
concentrated, or undergo another manipulation in advance of or
contemporaneously with fluid being drawn from the chamber 102 into the plurality of microfluidic networks 108, 1 10 by negative pressure induced by operation of downstream droplet ejectors 1 12, 1 14.
[0061 ] Further, as shown, the system 300 may include downstream fluid reservoirs 312, 314. A first fluid reservoir 312 may communicate the first channel 104 to the first droplet ejector 1 12 and may supply a volume of drive fluid to be ejected by the first droplet ejector 1 12. A second fluid reservoir 314 may communicate the second channel 106 to the second droplet ejector 1 14 and may supply a volume of drive fluid to be ejected by the second droplet ejector 1 14.
[0062] Processor-executable flow sequencing instructions 310 may provide different fluids to the chamber 102 with the input droplet ejectors 306, 308 according to a sequenced input flow. That is, different fluids may be introduced to the chamber 102 at different times by the different input droplet ejectors 306, 308. Sequenced input flow may be controlled according to the accumulating, mixing, reaction, concentrating, or other manipulation performed at the chamber 102
[0063] The processor-executable flow sequencing instructions 310 may further effect sequenced ejection of droplets at the downstream droplet ejectors 1 12, 1 14 based on the sequenced input flow of the different fluids into the chamber 102. That is, a sequence followed to draw fluid into the microfiuidic networks 108, 1 10 may be based on the sequenced generation of the fluid at the chamber 102 using the input droplet ejectors 306, 308. Input and output flow may be coordinated.
[0064] The processor-executable flow sequencing instructions 310 may sequence ejection of droplets at the downstream droplet ejectors 1 12, 1 14 based on a hold time of fluid in the chamber 102. A hold time may be used to allow mixing, concentrating, reacting, or similar manipulation to complete. As such, after ejection of droplets into the chamber 102 by the input droplet ejectors 306, 308, activation of the downstream droplet ejectors 1 12, 1 14 may be delayed so that a suitable fluid is generated at the chamber 102 prior to such fluid being drawn through the target microfiuidic networks 108, 1 10.
[0065] The processor-executable flow sequencing instructions 310 may sequence ejection of droplets at the downstream droplet ejectors 1 12, 1 14 based on a volume of fluid in the chamber 102. Volume may be computed from droplet ejection rate into the chamber 102 That is, a volumetric flow rate of input droplet ejectors 306, 308 may be stored in memory for reference by the instructions 310. A correlation of volumetric flow rates, such as a lookup table or function, may be provided for different ejection frequencies. Alternatively or additionally, as sensor 320 may be connected to the processor 1 16 and may be provide at the chamber 102. For example, sensing electrodes may be provided to the chamber 102 to determine volume of fluid in the chamber 102. Other types of sensors, such as inductive sensors, may be used. As such, a downstream droplet ejector 1 12, 114 may be activated when a particular volume of fluid is determined to be present in the chamber 102
[0088] As shown in FIG. 4, flow sequencing instructions 310 may control input droplet ejection rates 400, 402 of any number of droplet ejectors positioned provide different fluids to a mesofluidic chamber 102. Each fluid may be fed info the chamber 102 at a specific flow rate that may be controlled by a frequency of droplet ejection and a quantity of droplet ejection nozzles that are activated.
[0067] input droplet ejection rates 400, 402 may be varied over time to provide a specific fluid at the chamber 102 As such, fluid may be mixed, reacted, accumulated, concentrated, or otherwise generated in the chamber 102. Such fluid may then be selectively provided to target microfluidic networks 108, 1 10 positioned downstream of the chamber 102.
[0068] The flow sequencing instructions 310 may further control output droplet ejection rates 404, 406 of any number of droplet ejectors positioned downstream of the target microfluidic networks 108, 1 10 to draw selected fluid into the target microfluidic networks 108, 1 10. That is, when the chamber 102 contains a specific fluid that is intended for a specific target microfluidic network 108, 1 10, then the respective droplet ejection rate 404, 406 is controlled to draw the specific fluid into the specific target microfluidic network 108, 1 10 at a specific flow rate. The specific flow rate may be controlled by a frequency of droplet ejection and a quantity of droplet ejection nozzles that are activated. At the same time, other droplet ejection rates 404, 406 may be controlled to stop.
[0069] An increase to an output droplet ejection rate 404, 406 may be controlled to lag an increase to an input droplet ejection rate 400, 402 and such delay in movement of fluid from the chamber 102 may be used to implement a dwell time, to allow a reaction sufficient time to perform, or for a similar purpose
[0070] The chamber 102 acts as a mesofluidic interface between the input microfluid flow and output microfluidic flow. As such, the chamber 102 reduces complexity for mixing, reaction, or other fluid manipulation process that would otherwise require increased complexity to implement at the microfluidic scale.
[0071 ] FIG. 5 shows an example system 500. Features and aspects of the other devices and systems described herein may be used with the system 500 and vice versa. Like reference numerals denote like elements and description of like elements is not repeated here.
[0072] The system 500 includes a cartridge 502 including plurality of input droplet ejectors 308, 308 that dispense different fluids to a mesof!uidic chamber 102, a plurality of target microfluidic networks 108, 1 10 in fluid communication with the chamber 102, and a plurality of output droplet ejectors 1 12, 1 14 that induce negative pressure to draw fluid from the chamber 102 into the target microfluidic networks 108, 1 10. Such components may be contained within a cartridge housing 504.
[0073] The cartridge 502 further includes a signal interface 506 at the housing 504. The signal interface 506 is electrically connected to the droplet ejectors 306, 308, 1 12, 1 14 to receive a signal to sequence ejection of droplets to provide fluid to the chamber 102 and draw the fluid through target microfluidic networks 108, 1 10 The signal interface 506 may include an electrical contact.
[0074] The system 500 further includes an analysis device 508. The analysis device 508 includes a memory 1 18 and processor 1 16. The memory 1 18 may store flow sequencing instructions 310 for execution by the processor 1 16. The processor 1 16 is connected to an interface 510 that may include an electrical contact. The interface 510 provides for communications with the processor 1 16.
[0075] The cartridge 502 is removably mechanically connected to the analysis device 508. When the cartridge 502 is mechanically connected to the analysis device 508, the signal interface 506 of the cartridge 502 electrically connects to the interface 510 of the analysis device 508, so that the processor 1 16 may control the droplet ejectors 306, 308, 1 12, 1 14 and the target microfluidic networks 108, 1 10 according to the flow sequencing instructions 310. When the analytical process implemented by the cartridge 502 is complete, the resulting information may be communicated to the memory 1 18 or otheavise outputted and the cartridge 502 may be disconnected from the analysis device 508 and discarded.
[0076] FIG. 6 shows an example system 600 for a nucleic acid testing process. Features and aspects of the other devices and systems described herein may be used with the system 600 and vice versa. Like reference numerals denote like elements and description of like elements is not repeated here.
[0077] The system 600 includes a plurality of fluid ejection units 602 positioned to dispense fluid into a mesofluidic chamber 604. Each ejection unit includes a fluid reservoir 606, which may be pre!oaded or loaded at time of use, and an array of droplet ejectors 608. Different fluid ejection units 602 may provide different fluids to the mesofluidic chamber 604.
[0078] The chamber 604 may be funnel shaped to direct input fluid received from the fluid ejection units 602 to a fluid outlet that feeds a network of microfluidic channels 610. The chamber 604 includes a vent 612 to allow individual channels of the network of microfluidic channels 610 to function independently. A magnet 626, filter, or similar component that may be positioned near the outlet of the chamber 604 to interact with fluid in the chamber 604. in other examples, a magnet may be embedded in or attached to an inner wall of the funnel wall of the chamber 604. As such, a reagent may be made to contact or not contact the magnet, depending on relative positions of the magnet and the fluid ejection units 602. For example, magnetic material may be placed in the path of ejection of a particular fluid ejection unit 602 and outside a path of ejection of another fluid ejection unit 602.
[0079] The network of microfluidic channels 610 is communicates the chamber with first and second target microfluidic networks 108, 1 10 via first and second channels 614, 618 that terminate a respective first and second droplet ejectors 1 12, 1 14. Ejection of droplets at a droplet ejector 1 12, 1 14 induces a negative pressure that draws fluid from the chamber 604 through the respective target microfluidic network 108, 1 10.
[0080] The network of microfiuidic channels 610 may further include a third channel 620 that feeds a waste droplet ejector 622 that serves to clear fluid from the chamber 604 without flowing through a target microfiuidic network 108, 1 10. The waste droplet ejector 622 may connect with the third channel 620 via a fluid reservoir 628 that may be loaded with drive fluid. Ail output droplet ejectors 1 12, 1 14, 622 may eject to waste.
[0081 ] A processor 1 16 is connected to the droplet ejectors 608, 1 12, 1 14, 622 and activates the droplet ejectors 608, 1 12, 1 14, 622 based on flow sequencing instructions 624 that may be stored in a memory 1 18.
[0082] Fluid ejection units 602 may be provided for a wash buffer, an elution buffer, and a fluid containing a DNA/RNA sample. The flow sequencing instructions 624 may activate respective droplet ejectors to introduce the sample and wash buffer to the mesofluidic chamber 604 and draw resulting waste product through the waste channel 620. Sample material may be retained in the chamber 604 by a magnet 626, filter, or similar component that may be positioned near the outlet of the chamber 604. The flow sequencing instructions 624 may activate respective droplet ejectors to introduce elution buffer to the mesofluidic chamber 604 to elute the sample material and flow the resulting product through the first target microfiuidic network 108. A nucleic acid application process may then be initiated at the first target microfiuidic network 108. Fluid containing another sample may be ejected into the chamber 604 and the washing and elution processes may be repeated with resulting fluid being draw info the second target microfiuidic network 1 10, so that many nucleic acid application processes may be performed in a parallel staged manner using a plurality of target microfiuidic networks 108, 1 10.
[0083] An outcome of a test performed by a target microfiuidic network 108 may be used to modify parameters of a subsequent test performed by the next target microf!uidic network 1 10. For example, a low signal from a first DNA/RNA sample may be used to increase elution of a second DNA/RNA sample.
[0084] FIG. 7 shows an example method 700 of droplet ejection to sequence flow of fluid through target microfluidic networks to perform a nucleic acid testing process. The method 700 may be performed by any of the systems and devices described herein, such as the system 600 which will be referenced as an example. The method starts at block 702.
[0085] At block 704, fluid is provided to a chamber that feeds a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector. Different fluids may be provided to the chamber according to a sequenced input flow, in which different fluids are introduced to the chamber at different times. Different fluids may be inputted into the chamber by ejecting the different fluids into the chamber using different input droplet ejectors. For example, different input fluid ejection units 602 may be provided with a wash buffer, an elution buffer, and a fluid containing a DNA/RNA sample, and droplets of these fluids may be ejected into the chamber 604 at different times.
[0088] At block 706, ejection of droplets at the first droplet ejector and the second droplet ejector, located downstream of the chamber, may be sequenced to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network. The sequencing of ejection of droplets at the first droplet ejector and the second droplet ejector may occur after a hold time of fluid in the chamber. That is, input fluid may be allowed time to mix, react, concentrate, accumulate, or undergo other fluid manipulation prior to fluid being drawn from the chamber. The sequencing of ejection of droplets at the first droplet ejector and the second droplet ejector may be based on the sequenced input flow of the different fluids into the chamber. That is, a plurality of DNA/RNA samples may be provided to the chamber at different times. For example, a first DNA/RNA sample ejected info the chamber 604, after washing and elution, may be drawn from the chamber 604 to the first target microfluidic network 108 by activation of the first droplet ejector 1 12. Subsequently, a second DNA/RNA sample ejected into the chamber 604, after washing and elution, may be drawn from the chamber 604 to the second target microf!uidic network 1 10 by activation of the second droplet ejector 1 14.
[0087] At block 708, the first and second target microfluidic networks are controlled to perform an analytical process with fluid provided by action of the first and second droplet ejectors. For example, a PCR process may be performed by controlling a heater to temperature cycle fluid containing a
DNA/RNA sample. A first portion of a nucleic acid testing process may be performed at the first target microfluidic network and a second portion of the nucleic acid testing process may be performed at the second target microfluidic network. For example, each of a plurality of working DNA/RNA samples provided to the chamber 604 in sequence may be drawn into the respective target microfluidic network 108, 1 10 in sequence to perform a plurality of PCR processes in a time-staggered and parallel manner. The plurality of working DNA'RNA samples are contemplated to be from the same origin to avoid contamination. For example, an ejection unit 602 may be loaded with an original DNA/RNA sample that is to be analyzed by sequenced dispensing of working samples into the chamber 102. Samples may differ in concentration, preparation (e.g., isolation, washing, elution, etc.), or other parameter.
[0088] The method 700 may be repeated for different input fluids, different input fluid sequences, different fluid manipulations in the chamber, different output fluid sequences, or different operations of a target microfluidic network, via block 710. The method 700 then ends at block 712.
[0089] As should be apparent from the above, droplet ejectors or arrays thereof are used to input fluid to a mesofluidic chamber and draw fluid from the mesofluidic chamber according to a controllable sequence. Different fluid flow paths through different downstream targets may be decoupled from each other and further may be decoupled from flow paths into the mesofluidic chamber. The mesofluidic chamber may be used to mix, react, accumulate, concentrate, or perform other fluid manipulation on different inputted fluids. Input fluid flow and fluid flow through different downstream targets may be sequenced according to the needs of an analytical process implemented, such as a nucleic acid testing process.
[0090] it should be recognized that features and aspects of the various examples provided above can be combined into further examples that also fall within the scope of the present disclosure. In addition, the figures are not to scale and may have size and shape exaggerated for illustrative purposes.

Claims

1 A method comprising: providing fluid to a chamber, the chamber feeding a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector; sequencing ejection of droplets at the first droplet ejector and the second droplet ejector to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network; and controlling the first and second target microfiuidic networks to perform an analytical process with the fluid
2 The method of claim 1 , comprising providing different fluids to the chamber according to a sequenced input flow, in which different fluids are introduced to the chamber at different times.
3 The method of claim 2, further comprising sequencing ejection of droplets at the first droplet ejector and the second droplet ejector based on the sequenced input flow of the different fluids.
4. The method of claim 2, further comprising ejecting the different fluids into the chamber using different droplet ejectors.
5. The method of claim 1 , further comprising sequencing ejection of droplets at the first droplet ejector and the second droplet ejector based on a hold time of the fluid in the chamber or a determined volume of fluid in the chamber.
6. The method of claim 1 , further comprising performing a first portion of a nucleic acid testing process at the first target microfiuidic network and performing a second portion of the nucleic acid testing process at the second target microfiuidic network.
/. A device comprising: a non-transitory machine-readable medium including instructions that when executed by a processor cause the processor to: control input of a fluid to a chamber, the chamber feeding a first channel terminating at a first droplet ejector and a second channel terminating at a second droplet ejector; sequence an ejection of droplets at the first droplet ejector and the second droplet ejector to induce negative pressure to provide a sequenced output flow of the fluid through the first channel to a first target microfluidic network and through the second channel to a second target microfluidic network; and initiate an analytical process at the first and second target microfluidic networks
8 The device of claim 7, wherein the instructions are further to sequence input flow of different fluids into the chamber at different times.
9 The device of claim 8, wherein the instructions are further to sequence ejection of droplets at the first droplet ejector and the second droplet ejector based on the sequenced input flow of the different fluids.
10 The device of claim 7, wherein the instructions are further to delay ejection of droplets at the first droplet ejector and the second droplet ejector by a hold time of the fluid in the chamber.
1 1 The device of claim 7, wherein the instructions are further to initiate a nucleic acid testing process as the analytical process.
12 The device of claim 1 1 , wherein the instructions are further to perform a first portion of a nucleic acid testing process at the first target microfluidic network and perform a second portion of the nucleic acid testing process at the second target microfluidic network.
13 The device of claim 7 further comprising: the processor electrically connected to the non-transitory machine- readable medium; and an interface electrically connected to the processor, the interface to receive electrical connection of a removable cartridge, the removable cartridge including the chamber, the first channel, the first droplet ejector, the second channel, the second droplet ejector, the first target microfluidic network, and the second target microfluidic network
14. The device of claim 13, further comprising an input droplet ejector to provide the fluid to the chamber.
15. A device comprising: a housing; a chamber at the housing, the chamber to receive a fluid; a first channel communicating with the chamber; a first target microfluidic network communicating with the first channel, the first target microfluidic network to perform an analytical process with the fluid; a first droplet ejector at an end of the first channel; a second channel communicating with the chamber; a second target microfluidic network communicating with the second channel, the second target microfluidic network to cooperate with the first target microfluidic network to perform the analytical process; a second droplet ejector at an end of the second channel; and a signal interface at the housing and electrically connected to the first and second droplet ejectors to receive a signal to sequence ejection of droplets at the first and second droplet ejectors to draw the fluid through to first and second target microfluidic networks.
PCT/US2018/062365 2018-04-24 2018-11-22 Sequenced droplet ejection to deliver fluids Ceased WO2019209374A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/045,873 US11931738B2 (en) 2018-04-24 2018-11-22 Sequenced droplet ejection to deliver fluids

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
PCT/US2018/029169 WO2019209273A1 (en) 2018-04-24 2018-04-24 Microfluidic devices
USPCT/US2018/029169 2018-04-24
PCT/US2018/042411 WO2020018074A1 (en) 2018-07-17 2018-07-17 Droplet ejectors to provide fluids to droplet ejectors
PCT/US2018/042416 WO2020018075A1 (en) 2018-07-17 2018-07-17 Droplet ejectors to mix fluids
USPCT/US2018/042416 2018-07-17
PCT/US2018/042408 WO2020018073A1 (en) 2018-07-17 2018-07-17 Droplet ejectors with target media
USPCT/US2018/042408 2018-07-17
USPCT/US2018/042411 2018-07-17

Publications (1)

Publication Number Publication Date
WO2019209374A1 true WO2019209374A1 (en) 2019-10-31

Family

ID=68294620

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2018/062365 Ceased WO2019209374A1 (en) 2018-04-24 2018-11-22 Sequenced droplet ejection to deliver fluids
PCT/US2018/062366 Ceased WO2019209375A1 (en) 2018-04-24 2018-11-22 Droplet ejectors to draw fluids through microfluidic networks

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2018/062366 Ceased WO2019209375A1 (en) 2018-04-24 2018-11-22 Droplet ejectors to draw fluids through microfluidic networks

Country Status (2)

Country Link
US (2) US20210031188A1 (en)
WO (2) WO2019209374A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230241605A1 (en) * 2022-01-31 2023-08-03 Tdk U.S.A. Corporation Devices and Methods for Flow Control of Single Cells or Particles

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179423B2 (en) * 2001-06-20 2007-02-20 Cytonome, Inc. Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
US7456012B2 (en) * 1997-11-06 2008-11-25 Cellectricon Ab Method and apparatus for spatially confined electroporation
US8426209B2 (en) * 2003-08-28 2013-04-23 Celula, Inc. Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network
US20140051604A1 (en) * 2006-02-07 2014-02-20 Stokes Bio Limited Microfluidic droplet queuing network
WO2016175864A1 (en) * 2015-04-30 2016-11-03 Hewlett-Packard Development Company, L.P. Target constituent location and discharge
US20180015473A1 (en) * 2014-04-10 2018-01-18 10X Genomics, Inc. Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329698A (en) 1980-12-19 1982-05-11 International Business Machines Corporation Disposable cartridge for ink drop printer
US4614953A (en) 1984-04-12 1986-09-30 The Laitram Corporation Solvent and multiple color ink mixing system in an ink jet
US4877745A (en) 1986-11-17 1989-10-31 Abbott Laboratories Apparatus and process for reagent fluid dispensing and printing
SE465742B (en) 1989-04-26 1991-10-21 Migrata Uk Ltd KYVETT BEFORE RECORDING FOR AT LEAST ONE FLUID
US5032850A (en) 1989-12-18 1991-07-16 Tokyo Electric Co., Ltd. Method and apparatus for vapor jet printing
US5587128A (en) 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US5892524A (en) 1995-04-12 1999-04-06 Eastman Kodak Company Apparatus for printing multiple drop sizes and fabrication thereof
AUPN522395A0 (en) 1995-09-06 1995-09-28 Eastman Kodak Company Ink composition based on a microemulsion
WO1998010866A1 (en) 1996-09-16 1998-03-19 Alphahelix Ab Cartridge and system for storing and dispensing of reagents
US20020092767A1 (en) 1997-09-19 2002-07-18 Aclara Biosciences, Inc. Multiple array microfluidic device units
JP4321738B2 (en) 1998-06-24 2009-08-26 チェン アンド チェン エルエルシー Liquid sample test system
JP2000108339A (en) 1998-09-30 2000-04-18 Xerox Corp Print head for ballistic aerosol printer
EP1157270A1 (en) * 1999-02-03 2001-11-28 Aclara BioSciences, Inc. Multichannel control in microfluidics
US6221653B1 (en) 1999-04-27 2001-04-24 Agilent Technologies, Inc. Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids
US6322327B1 (en) 2000-01-13 2001-11-27 Walker-Dawson Interests, Inc. Jet pump for transfer of material
AU2002211389A1 (en) 2000-10-03 2002-04-15 California Institute Of Technology Microfluidic devices and methods of use
CA2460192C (en) 2001-09-11 2011-04-19 Iquum, Inc. Sample vessels
US6464336B1 (en) 2001-10-31 2002-10-15 Eastman Kodak Company Ink jet printing with color-balanced ink drops mixed using bleached ink
US6550892B1 (en) 2001-11-12 2003-04-22 Eastman Kodak Company Ink jet printing with pre-mixed, color-balanced ink drops
AU2002366369A1 (en) 2001-12-18 2003-06-30 Lynx Therapeutics, Inc. METHOD FOR APPLYING A pH GRADIENT TO A MICROCHANNEL DEVICE
US7410615B2 (en) 2002-01-24 2008-08-12 Perkinelmer Las, Inc. Precision liquid dispensing system
EP1528086B1 (en) 2002-07-17 2016-02-24 DNP Fine Chemicals Co., Ltd. Oil-based ink composition for ink-jet recording
US7419638B2 (en) 2003-01-14 2008-09-02 Micronics, Inc. Microfluidic devices for fluid manipulation and analysis
US7448734B2 (en) 2004-01-21 2008-11-11 Silverbrook Research Pty Ltd Inkjet printer cartridge with pagewidth printhead
US20070095393A1 (en) 2004-03-30 2007-05-03 Piero Zucchelli Devices and methods for programmable microscale manipulation of fluids
JP5007016B2 (en) 2004-06-10 2012-08-22 理想科学工業株式会社 Oil-based inkjet ink
JP2008528170A (en) 2005-01-31 2008-07-31 ギブン・イメージング・リミテツド In vivo analysis device, apparatus and method
JP2006305902A (en) 2005-04-28 2006-11-09 Brother Ind Ltd Inkjet recording device
CN101242956B (en) 2005-07-13 2010-10-27 富士胶片迪麦提克斯公司 droplet ejection method
US7915030B2 (en) 2005-09-01 2011-03-29 Canon U.S. Life Sciences, Inc. Method and molecular diagnostic device for detection, analysis and identification of genomic DNA
KR20070025634A (en) 2005-09-03 2007-03-08 삼성전자주식회사 Inkjet Printheads and Manufacturing Method Thereof
US20080252679A1 (en) 2005-10-07 2008-10-16 Koninklijke Philips Electronics, N.V. Ink Jet Device for the Controlled Positioning of Droplets of a Substance Onto a Substrate, Method for the Controlled Positioning of Droplets of a Substrate, and Use of an Ink Jet Device
US7658477B2 (en) 2005-11-11 2010-02-09 Ricoh Company, Ltd. Liquid ejecting head, imaging forming apparatus, device for ejecting a liquid drop, and recording method
US7763453B2 (en) 2005-11-30 2010-07-27 Micronics, Inc. Microfluidic mixing and analytic apparatus
CN101341221B (en) 2006-03-09 2011-07-27 佳能株式会社 Pigment ink, ink set, inkjet recording method, ink cartridge, recording unit, inkjet recording apparatus, and image forming method
ES2393758T3 (en) 2006-03-15 2012-12-27 Micronics, Inc. Integrated nucleic acid assays
WO2008024319A2 (en) 2006-08-20 2008-02-28 Codon Devices, Inc. Microfluidic devices for nucleic acid assembly
EP1935652B1 (en) 2006-12-21 2010-04-21 Agfa Graphics N.V. Inkjet Printing methods and ink sets
US20100143905A1 (en) 2007-03-29 2010-06-10 Lane Michael J Methods and compositions for multivalent binding and methods for manufacture of rapid diagnostic tests
US8123396B1 (en) 2007-05-16 2012-02-28 Science Applications International Corporation Method and means for precision mixing
US8133671B2 (en) 2007-07-13 2012-03-13 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US9795697B2 (en) 2007-09-19 2017-10-24 Opko Diagnostics, Llc Liquid containment for integrated assays
JP5523327B2 (en) 2007-10-12 2014-06-18 レオニックス,インコーポレイテッド Integrated microfluidic device and method
EP3586945A3 (en) 2009-06-05 2020-03-04 IntegenX Inc. Universal sample preparation system and use in an integrated analysis system
US8746285B2 (en) 2009-09-04 2014-06-10 Auburn University Programmable fluidic droplet generation
KR101040085B1 (en) 2009-09-29 2011-06-09 아메스산업(주) Reagent Synthesis Unit with Syringe Pump Unit Premixable
CA2786569C (en) 2010-01-29 2019-04-09 Perkinelmer Health Sciences, Inc. Sample-to-answer microfluidic cartridge
US9645162B2 (en) 2010-08-27 2017-05-09 Hewlett-Packard Development Company, L.P. Automated assay fluid dispensing
US8517518B2 (en) 2010-11-09 2013-08-27 Canon Kabushiki Kaisha Recording apparatus and liquid ejection head
EP2670810A4 (en) 2011-01-31 2014-04-16 Hewlett Packard Development Co Emulsion-based thermal inkjet inks
EP2691676B1 (en) 2011-03-30 2019-03-27 Bio-Rad Laboratories, Inc. Injection of multiple volumes into or out of droplets
US9138714B2 (en) 2011-10-31 2015-09-22 General Electric Company Microfluidic chip and a related method thereof
US9738887B2 (en) 2012-02-13 2017-08-22 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
EP2825309B1 (en) 2012-03-16 2018-05-16 Stat-Diagnostica & Innovation, S.L. A test cartridge with integrated transfer module
JP6200948B2 (en) 2012-05-25 2017-09-20 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル Microfluidic device
US9523013B2 (en) 2012-11-20 2016-12-20 Hewlett-Packard Development Company, L.P. Non-aqueous microemulsion inkjet ink
US11110458B2 (en) 2013-02-01 2021-09-07 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
ES2939140T3 (en) 2013-08-08 2023-04-19 Illumina Inc Fluid system for the supply of reagents to a flow cell
GB201401426D0 (en) 2014-01-28 2014-03-12 Univ Strathclyde Automated Assay
SG11201605507SA (en) 2014-01-29 2016-08-30 Hewlett Packard Development Co Microfluidic valve
DE102014206140A1 (en) 2014-04-01 2015-10-01 Robert Bosch Gmbh A microfluidic device and method for analyzing a sample of biological material
KR101493035B1 (en) 2014-07-24 2015-02-17 주식회사 우심시스템 Ink cartridge for ink-jet Printer rechargeable ink personally
CN107873054B (en) 2014-09-09 2022-07-12 博德研究所 Droplet-based methods and apparatus for multiplexed single-cell nucleic acid analysis
CN107073953B (en) 2014-10-31 2018-09-04 惠普发展公司,有限责任合伙企业 Fluid ejection device
KR102587637B1 (en) 2014-12-12 2023-10-10 옵코 다이어그노스틱스, 엘엘씨 Fluidic systems comprising an incubation channel, including fluidic systems formed by molding
FR3030312B1 (en) * 2014-12-23 2019-09-27 Albea Le Treport SYSTEM FOR DISPENSING A FLUID PRODUCT
WO2016170008A1 (en) 2015-04-20 2016-10-27 Ventana Medical Systems, Inc. Inkjet deposition of reagents for histological samples
JP6516612B2 (en) 2015-07-24 2019-05-22 キヤノン株式会社 Liquid discharge head and liquid discharge device
US11698332B2 (en) 2015-11-24 2023-07-11 Hewlett-Packard Development Company, L.P. Devices having a sample delivery component
AU2017249317B2 (en) 2016-04-11 2019-12-12 Altopa, Inc. Secure portable, on-demand, microfluidic mixing and dispensing device
TWI666398B (en) 2016-07-13 2019-07-21 台達電子國際(新加坡)私人有限公司 Fluid control device
EP3592565A4 (en) 2017-07-06 2020-04-22 Hewlett-Packard Development Company, L.P. Ink supply
EP3720606A4 (en) 2017-07-27 2021-05-05 Board Of Regents, The University Of Texas System AMPLIFICATION OF MRNA SEQUENCES CODING PAIRED PROTEINS
DE102018103049A1 (en) 2018-02-12 2019-08-14 Karlsruher Institut für Technologie Printhead and printing process
US11279137B2 (en) 2018-07-17 2022-03-22 Hewlett-Packard Development Company, L.P. Droplet ejectors aimed at target media
JP7305955B2 (en) 2018-12-28 2023-07-11 株式会社リコー Liquid ejection head, liquid ejection device, dispensing device, and liquid ejection method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456012B2 (en) * 1997-11-06 2008-11-25 Cellectricon Ab Method and apparatus for spatially confined electroporation
US7179423B2 (en) * 2001-06-20 2007-02-20 Cytonome, Inc. Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
US8426209B2 (en) * 2003-08-28 2013-04-23 Celula, Inc. Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network
US20140051604A1 (en) * 2006-02-07 2014-02-20 Stokes Bio Limited Microfluidic droplet queuing network
US20180015473A1 (en) * 2014-04-10 2018-01-18 10X Genomics, Inc. Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same
WO2016175864A1 (en) * 2015-04-30 2016-11-03 Hewlett-Packard Development Company, L.P. Target constituent location and discharge

Also Published As

Publication number Publication date
WO2019209375A1 (en) 2019-10-31
US20210031188A1 (en) 2021-02-04
US11931738B2 (en) 2024-03-19
US20210138458A1 (en) 2021-05-13

Similar Documents

Publication Publication Date Title
CN104487562B (en) Biochemical treatment apparatus
TWI382174B (en) Microtray for handling biosubstances,fluid handling system and microplate
US11478791B2 (en) Flow control and processing cartridge
US11478795B2 (en) Microfluidic device and method for analyzing nucleic acids
US20210245153A1 (en) Analyte capturing devices with fluidic ejection devices
US11931738B2 (en) Sequenced droplet ejection to deliver fluids
US11761459B2 (en) Inertial pump fluid dispensing
US11279137B2 (en) Droplet ejectors aimed at target media
CN108339578A (en) Drop injector and use its drop sample injection method
TWI617358B (en) Polymerase chain reaction device and method therefor
JP2008249720A (en) Droplet dispensing system
CN113244969A (en) Liquid dispensing system, microfluidic sample carrier sealing system and method of dispensing sealing liquid using the dispensing system
US12071657B2 (en) Nucleic acid amplification
US20210322970A1 (en) Droplet ejectors to mix fluids
EP1920844B1 (en) Apparatus for introducing fluid into microfluidic chip by using centrifugal force
US11325380B2 (en) Droplet ejectors to provide fluids to droplet ejectors
US20210023555A1 (en) Chambers to receive fluids by negative pressures
US11547993B2 (en) Droplet ejectors with target media
EP3775832B1 (en) Conductivity-based reaction chamber control
US12145149B2 (en) Disposable microfluidic cassettes
US20160067733A1 (en) Apparatuses and methods for dispensing predetermined quantities of liquid onto a substrate
WO2024205553A1 (en) Fluid ejection system
US12337312B2 (en) Microfluidic dispensers for limiting dilution

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18915921

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18915921

Country of ref document: EP

Kind code of ref document: A1